The current address for B. and M. Mackness is PONTECH, 27 Cote Green Road, Marple Bridge, Stockport SK6 5EW, UK.
Glycation of paraoxonase-1 inhibits its activity and impairs the ability of high-density lipoprotein to metabolize membrane lipid hydroperoxides
Article first published online: 29 AUG 2008
© 2008 The Authors. Journal compilation © 2008 Diabetes UK
Volume 25, Issue 9, pages 1049–1055, September 2008
How to Cite
Mastorikou, M., Mackness, B., Liu, Y. and Mackness, M. (2008), Glycation of paraoxonase-1 inhibits its activity and impairs the ability of high-density lipoprotein to metabolize membrane lipid hydroperoxides. Diabetic Medicine, 25: 1049–1055. doi: 10.1111/j.1464-5491.2008.02546.x
- Issue published online: 29 AUG 2008
- Article first published online: 29 AUG 2008
- Accepted 4 July 2008
- 4for the Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. N Engl J Med 1999; 341: 410–418., , , , et al .
- 11Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J Clin Invest 1991; 88: 2039–2046., , , , , et al .
- 23WHO. Second Report of the WHO Expert Committee on Diabetes Mellitus. WHO Technical Report Series No. 646. Geneva: World Health Organization, 1980.
- 24Lipoprotein separation and analysis for clinical studies. In: ConverseCA, SkinnerER, eds. Lipoprotein Analysis: A Practical Approach. Oxford: IRL Press, 1992; 1–42., .
- 26Oxidised lipoproteins and atherosclerosis. In: FusterV, RossR, TopolEJ, eds. Atherosclerosis and Coronary Artery Disease. Philadelphia: Lippincott-Raven, 1996; 129–149., .
- 33Paraoxonase active site required for protection against LDL oxidation involves its free sulphydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase alloenzymes Q and R. Arterioscl Thromb Vasc Biol 1998; 10: 1617–1624., , , , , et al .